Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen in ...
EMA committee recommends approval of Sanofi & Regeneron’s Dupixent to treat eosinophilic esophagitis in children as young as 1 year old: Paris Monday, September 23, 2024, 11:00 ...
Scarlett Mitchell, from the Scottish Highlands, has tried dozens of treatments and medications - from steroids and immunosuppressant injections to light therapy - to help her severe eczema ...